Skip to main content
Premium Trial:

Request an Annual Quote

NABsys Licenses Nanopore IP for DNA Sequencing from Brown University in Exchange for Equity

NEW YORK, Aug. 10 (GenomeWeb News) - NABsys has exclusively licensed nanopore technology from Brown University to commercialize it for DNA sequencing, the Providence, RI-based company said today.

 

Under the agreement, NABsys obtains exclusive worldwide rights to certain intellectual property in exchange for a "significant equity interest" issued to Brown University.

 

The nanopore technology was developed by Xinsheng Sean Ling, an associate professor of physics at Brown and a co-founder of NABsys. Ling recently received a $1.55 million grant from the National Science Foundation to pursue his research.

 

Earlier this week, the National Human Genome Research Institute awarded 12 grants totaling more than $32 million to advance DNA sequencing technologies, four of which involve nanopore technology.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.